Ernesto Vigna Selected Research

Ernesto Vigna Research Topics

Disease

22	Multiple Myeloma 05/2024 - 05/2013
14	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 03/2008
7	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 09/2016
6	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 04/2024 - 04/2004
5	Neoplasms (Cancer) 05/2024 - 03/2017
4	Anemia 04/2024 - 09/2008
4	Residual Neoplasm 04/2024 - 01/2015
4	Disease Progression 01/2024 - 04/2011
3	Primary Myelofibrosis (Myelosclerosis) 04/2024 - 01/2011
3	Leukemia 01/2024 - 01/2015
3	Thrombotic Thrombocytopenic Purpura 07/2023 - 04/2018
2	Thrombocytopenia (Thrombopenia) 10/2021 - 04/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2017 - 03/2014
1	Sudden Death 01/2024
1	Heart Failure 01/2024
1	Infections 01/2024
1	Hemorrhage 01/2024
1	Thrombotic Microangiopathies 07/2023
1	COVID-19 07/2023
1	Hyperplasia 05/2023
1	Iron Overload 05/2023
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2021
1	Philadelphia Chromosome 07/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020
1	Ischemia 04/2018
1	Hemolytic Anemia 04/2018
1	Neutropenia 11/2017
1	Body Weight (Weight, Body) 07/2017
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2015
1	Smoldering Multiple Myeloma 04/2015

Drug/Important Bio-Agent (IBA)

13	Lenalidomide (CC 5013)FDA Link 01/2024 - 02/2011
9	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 09/2008
6	elotuzumabIBA 01/2023 - 01/2021
5	Rituximab (Mabthera)FDA Link 04/2021 - 09/2008
5	Dasatinib (BMS 354825)FDA Link 01/2020 - 03/2014
4	ibrutinibIBA 01/2024 - 01/2021
4	Immunomodulating AgentsIBA 10/2023 - 06/2013
4	Proteasome InhibitorsIBA 10/2023 - 06/2013
4	Bendamustine Hydrochloride FDA Link 01/2021 - 11/2013
4	Proteins (Proteins, Gene)FDA Link 04/2015 - 03/2008
3	thiamine triphosphorate (TTP)IBA 07/2023 - 04/2018
3	carfilzomibIBA 12/2022 - 01/2022
3	ponatinibIBA 07/2021 - 01/2017
3	Melphalan (Alkeran)FDA LinkGeneric 03/2017 - 05/2013
2	Monoclonal AntibodiesIBA 05/2024 - 10/2023
2	caplacizumabIBA 07/2023 - 04/2023
2	Deferasirox FDA Link 05/2023 - 06/2014
2	venetoclaxIBA 01/2023 - 11/2017
2	acalabrutinibIBA 01/2023 - 01/2020
2	pomalidomideIBA 01/2023 - 01/2017
2	Hemoglobins (Hemoglobin)IBA 07/2017 - 09/2008
2	Bortezomib (Velcade)FDA Link 03/2017 - 11/2015
2	Imatinib Mesylate (Gleevec)FDA Link 01/2017 - 04/2008
2	SteroidsIBA 01/2017 - 09/2008
1	fms-Like Tyrosine Kinase 3IBA 05/2024
1	CytokinesIBA 04/2024
1	N- (cyanomethyl)- 4- (2- ((4- (4- morpholinyl)phenyl)amino)- 4- pyrimidinyl)benzamideIBA 04/2024
1	Janus Kinase InhibitorsIBA 04/2024
1	blinatumomabIBA 04/2024
1	selinexorIBA 03/2024
1	tagraxofuspIBA 10/2023
1	luspaterceptIBA 10/2023
1	zanubrutinibIBA 09/2023
1	glasdegibIBA 09/2023
1	ivosidenibIBA 09/2023
1	belantamab mafodotinIBA 05/2023
1	DeferiproneIBA 05/2023
1	Chelating AgentsIBA 05/2023
1	Deferoxamine (Desferal)FDA LinkGeneric 05/2023
1	IronIBA 05/2023
1	Azacitidine (5 Azacytidine)FDA Link 04/2023
1	isatuximabIBA 01/2023
1	Inosine Triphosphate (ITP)IBA 10/2021
1	eltrombopag FDA Link 10/2021
1	Tyrosine Kinase InhibitorsIBA 07/2021
1	idelalisibIBA 04/2021
1	eculizumab FDA Link 04/2018
1	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 03/2017
1	PanobinostatIBA 09/2016
1	Sorafenib (BAY 43-9006)FDA Link 06/2016
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2016
1	Thalidomide (Thalomid)FDA Link 11/2015
1	betaglycan (TGFBR3)IBA 08/2015
1	Histone Deacetylase InhibitorsIBA 06/2015
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 06/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2015
1	fludarabineIBA 06/2015
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2015
1	Chimeric Antigen ReceptorsIBA 06/2015
1	ixazomibIBA 01/2015

Therapy/Procedure

19	Therapeutics 05/2024 - 04/2008
6	Drug Therapy (Chemotherapy) 10/2023 - 05/2013
4	Salvage Therapy 12/2022 - 01/2021
3	Stem Cell Transplantation 11/2015 - 04/2004
1	Homologous Transplantation 07/2021
1	Hematopoietic Stem Cell Mobilization 03/2021
1	Hematopoietic Stem Cell Transplantation 01/2020